Serina Therapeutics (SER) Share-based Compensation (2018 - 2025)
Serina Therapeutics (SER) posted Share-based Compensation of $948,000 for Q4 2025, down 4.0% from $988,000 a year earlier and down 5.1% from the prior quarter.
Powered by 
Analysis
Serina Therapeutics (SER) Share-based Compensation (2018 - 2025) Analysis & Trends
For FY2025, Serina Therapeutics' Share-based Compensation came in at $3.79 million, up 46.2% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 33.1% (FY2020 to FY2025).
- In prior years, Serina Therapeutics' Share-based Compensation was $2.6 million in FY2024, $25,000 in FY2023 (-96.7%), $760,000 in FY2022 (-23.9%) and $999,000 in FY2021 (+9.9%).
- Quarterly Share-based Compensation has run from a low of $2,000 in Q1 2023 to a high of $1.1 million in Q3 2024 over five years.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2025, with growth of 94.3%; the weakest was Q1 2023, with a decline of 99.2%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $999,000 (Q3 2025), $890,000 (Q2 2025) and $956,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Serina Therapeutics | 32.93 Mn | -7.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 948,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Jun 30, 2025 | 890,000.00 |
| Mar 31, 2025 | 956,000.00 |
| Dec 31, 2024 | 988,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 458,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 114,000.00 |
| Sep 30, 2022 | 209,000.00 |
| Jun 30, 2022 | 198,000.00 |
| Mar 31, 2022 | 239,000.00 |
| Dec 31, 2021 | 263,000.00 |
| Sep 30, 2021 | 272,000.00 |
| Jun 30, 2021 | 286,000.00 |
| Mar 31, 2021 | 178,000.00 |
| Dec 31, 2020 | 158,000.00 |
| Sep 30, 2020 | 232,000.00 |
API Access
Serina Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();